Response to "Roxadustat: More Than an Erythropoietic Agent?"
Kidney Int Rep
.
2024 Oct 28;10(1):276.
doi: 10.1016/j.ekir.2024.10.020.
eCollection 2025 Jan.
Authors
Weiwei Kong
1
2
3
4
,
Xiaoying Wu
1
2
3
4
,
Hongfeng Huang
1
2
3
4
Affiliations
1
Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang, China.
2
Institute of Nephrology, Zhejiang University, Zhejiang, China.
3
Key Laboratory of Kidney Disease Prevention and Control Technology, Zhejiang Province, Zhejiang, China.
4
Zhejiang Clinical Research Center of Kidney and Urinary System Disease, Hangzhou, Zhejiang, China.
PMID:
39810786
PMCID:
PMC11725801
DOI:
10.1016/j.ekir.2024.10.020
No abstract available